EBSWORTH DAVID R 4
4 · Verona Pharma plc · Filed May 5, 2025
Insider Transaction Report
Form 4
EBSWORTH DAVID R
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2025-05-01$1.93/sh+140,000$270,732→ 1,476,003 total - Exercise/Conversion
Stock Option (Right to Exercise)
2025-05-01+140,000→ 0 totalExercise: $1.93Exp: 2034-04-28→ Ordinary Shares (140,000 underlying)
Footnotes (4)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]Consists of (i) 1,476,000 Ordinary Shares represented by 184,500 ADSs and (ii) 3 Ordinary Shares.
- [F3]The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F4]The option is fully vested.